Abbott Laboratories said it is pulling prescription weight-loss drug Meridia from the U.S., Canadian and Australian markets, following a study suggesting it increased risk of serious cardiovascular events in patients with heart problems.
WSJ.com: What's News US, Wall Street Journal
Fri, 10/08/2010 - 9:27am
Abbott Laboratories said it is pulling prescription weight-loss drug Meridia from the U.S., Canadian and Australian markets, following a study suggesting it increased risk of serious cardiovascular events in patients with heart problems.